Skip to main content
Oxford Biomedica PLC logo

Oxford Biomedica PLC — Investor Relations & Filings

Ticker · OXB ISIN · GB00BDFBVT43 LEI · 213800S1GVQNXQ15K851 IL Manufacturing
Open in API
Filings indexed 912 across all filing types
Latest filing 2026-05-22 Director's Dealing
Country GB United Kingdom
Listing IL OXB

About Oxford Biomedica PLC

https://www.oxb.com/

Oxford Biomedica (OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. A pioneer in the field, the company has extensive experience in viral vectors, the enabling technology for many advanced therapies. OXB provides end-to-end services to pharmaceutical and biotechnology partners, supporting programs from preclinical development through to commercial launch. Its core expertise includes the development and GMP manufacturing of various vector types, including lentivirus, adeno-associated virus (AAV), and adenovirus. The company offers proprietary technologies like its LentiVector™ platform, the first commercially approved lentiviral system, and its inAAVate™ platform for AAV, in addition to tech-transfer capabilities.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing share transactions (option exercises and sales) by Persons Discharging Managerial Responsibilities (PDMRs). It reports insider dealings, including exact volumes, prices, and transaction types. This matches the “Director’s Dealing” category, which covers personal share transactions by company directors and executives under market abuse regulation.
2026-05-22 English
PDMR Dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing an insider transaction by a Person Discharging Managerial Responsibilities (PDMR) – the exercise and disposal of share units by a senior executive. This clearly matches the definition of a Director’s Dealing report (insider share transactions).
2026-05-19 English
PDMR Dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing personal share transactions by Persons Discharging Managerial Responsibilities (PDMRs) – officers exercising options and selling shares under EU Market Abuse Regulation. This exactly matches insider/director dealings. Therefore, it should be classified as Director's Dealing (DIRS).
2026-05-13 English
Print of AGM Resolutions
AGM Information Classification · 93% confidence The document is the formal record of resolutions passed at the Annual General Meeting of Oxford Biomedica plc on 7 May 2026, detailing ordinary and special resolutions adopted by shareholders (adoption of reports, reappointments, share authorities, etc.). It is part of the AGM materials rather than an earnings release, financial report, or notice of voting results with tallies. It fits the AGM Information category.
2026-05-11 English
AGM Minutes
AGM Information Classification · 100% confidence The document is titled 'Minutes of the Annual General Meeting of the Company' and details the proceedings of the AGM held on 07 May 2026. It includes attendance, quorum confirmation, and the results of multiple resolutions proposed and carried at the meeting. There is no indication that this is a report of financial performance or an announcement of voting results alone; rather, it is the official record of the AGM proceedings. The document length is about 4815 characters, which is sufficient for detailed minutes. Therefore, the document fits the category of AGM Information (AGM-R).
2026-05-07 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Result of Annual General Meeting' and dated 07 May 2026. It details the voting results of resolutions passed at the company's AGM, including adoption of the Annual Report and accounts for the financial year ended 31 December 2025, reappointment of directors, auditor appointments, and authorizations related to shares. The document is a formal announcement of the voting outcomes at the AGM, not the full Annual Report or financial statements themselves. It includes detailed voting percentages and results, which is typical for a Declaration of Voting Results document. The document length is 7659 characters, which is consistent with a detailed voting result announcement rather than a full report. Therefore, the correct classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-07 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.